Primary cutaneous Rosai-Dorfman disease; a case-based review of a diagnostically and therapeutically challenging rare variant.


Journal

Annals of diagnostic pathology
ISSN: 1532-8198
Titre abrégé: Ann Diagn Pathol
Pays: United States
ID NLM: 9800503

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 20 09 2019
accepted: 01 10 2019
pubmed: 25 1 2020
medline: 7 1 2021
entrez: 25 1 2020
Statut: ppublish

Résumé

Primary cutaneous Rosai-Dorfman disease is a rare form of Rosai-Dorfman disease limited to the skin. The diagnosis of primary cutaneous disease is based on a combination of clinical presentation, histopathology, and the detection of S100+, CD68+, and CD1a- histiocytic immunophenotyping. However, the diagnosis of primary cutaneous disease is often difficult and significantly delayed due to the non-specific nature of its histologic and clinical features. In this review, we describe four cases in order to familiarize pathologists and dermatopathologists with the clinicopathologic correlation of primary cutaneous Rosai-Dorfman disease and to help facilitate early diagnosis. In addition, we discuss the proposed pathophysiology and molecular etiology of this tumor, and its relationship with IgG4 sclerosing disease.

Identifiants

pubmed: 31978810
pii: S1092-9134(19)30375-2
doi: 10.1016/j.anndiagpath.2019.151446
pii:
doi:

Substances chimiques

Antigens, CD 0
Antigens, CD1 0
Antigens, Differentiation, Myelomonocytic 0
CD1a antigen 0
CD68 antigen, human 0
S100 Proteins 0
Steroids 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

151446

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts, financial or otherwise, to disclose.

Auteurs

Rachel Fayne (R)

Department of Dermatopathology and Pathology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Sandra Sanchez Rengifo (SS)

Department of Pathology, Hematopathology Division, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Ivan Gonzalez (I)

Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Jose Luis Solorzano (JL)

Department of Pathology, Hematopathology Division, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Daniel Gonzalez (D)

Department of Dermatopathology and Pathology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Francisco Vega (F)

Department of Pathology, Hematopathology Division, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA.

Jeong Hee Cho-Vega (JH)

Department of Dermatopathology and Pathology, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: Vegaelena@ymail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH